Richtlijn: Erfelijke darmkanker (1.0) - Genootschap van Maag-Darm ...

More documents

Recommendations

Info

Richtlijn: Erfelijke darmkanker (1.0)241 - Norum JNorum J, Tranebjaerg L. Health, life and disability insurance and hereditary risk for breast or colorectalcancer. Acta Oncol 2000;39:189-93.242 - Nugent KPNugent KP, Phillips RK. Rectal cancer risk in older patients with familial adenomatous polyposis and anileorectal anastomosis: A cause for concern. Br J Surg 1992;79:1204-6.243 - Nugent KPNugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effecton duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. BrJ Surg 1993;80:1618-9.244 - Oei ALOei AL, Massuger LF, Bulten J, Ligtenberg MJ, Hoogerbrugge N, de Hullu JA. Surveillance of women athigh risk for hereditary ovarian cancer is inefficient. Br J Cancer 2006;94:814-819.245 - Offerhaus GJAOfferhaus GJA, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC et al. The risk of uppergastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992;102:1980-2.246 - Offit KOffit K, Groeger S, Turner S, Wadsworth EA, Weiser MA. The 'duty to warn' a patient's family membersabout hereditary disease risks. JAMA 2004;292:1469-73.247 - Offit KOffit K, Kohut K, Clagett B, Wadsworth EA, Lafaro KJ, Cummings S et al. Cancer genetic testing andassisted reproduction. J Clin Oncol 2006;24:4775-82.248 - Offringa MOffringa M, Assendelft WJJ, Scholten RJPM, red. Bohn Stafleu Van Loghum. Inleiding in Evidence-basedMedicine. Klinisch handelen gebaseerd op bewijsmateriaal., Houten, 2003.249 - Ogino SOgino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, Weisenberger DJ et al. CpG islandmethylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylationanalysis and prospective cohort studies. Gut 2006;55:1000-6.250 - Olivier RIOlivier RI, Lubsen-Brandsma MA, Verhoef S, van Beurden M. CA125 and transvaginal ultrasoundmonitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol2006;100:20-6.251 - Olivier RIOlivier RI, van Beurden M, Lubsen MA, Rookus MA, Mooij TM, van de Vijver MJ et al. Clinical outcome ofprophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. Br J Cancer2004;90:1492-7.252 - Oosterwijk JCOosterwijk JC, Ausems MGEM. Trends binnen de klinische genetica. Gebruik van erfelijkheidsonderzoekin de patiëntenzorg neemt toe. Med Contact 2005;60:1880-3.03/11/08 Erfelijke darmkanker (1.0) 105
Richtlijn: Erfelijke darmkanker (1.0)253 - van Oostrom Ivan Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RHet al. Experience of parental cancer in childhood is a risk factor for psychological distress during geneticcancer susceptibility testing. Ann Oncol 2006;17:1090-5.254 - van Oostrom Ivan Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RHet al. Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC geneticsusceptibility testing. Eur J Cancer 2007;43:71-7.255 - Petersen GMPetersen GM. Genetic testing and counselling in familial adenomatous polyposis. Oncology1996;10:89-94.256 - Peterson SKPeterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK et al. How familiescommunicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet2003;119C:78-86.257 - Phillips RKPhillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP et al. A randomized, double blind,placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis infamilial adenomatous polyposis. Gut 2002;50:857-60.258 - Pieterse AHPieterse AH , Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counselingconsultation: change in counselees' cognitions and anxiety, and association with addressing their needsand preferences. Am J Med Genet A. 2005;137:27-35.259 - Pieterse AHPieterse AH, Van Dulmen AM, Ausems MG, Beemer FA, Bensing JM. Communication in cancer geneticcounselling: does it reflect counselees' previsit needs and preferences? Br J Cancer 2005;92:1671-8.260 - Pieterse AHPieterse AH, Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counselingconsultation: change in counselees' cognitions and anxiety, and association with addressing their needsand preferences. Am J Med Genet 2005;A 137:27-35.261 - Piñol VPiñol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X et al. Gastrointestinal Oncology Group ofthe Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatelliteinstability, and immunohistochemistry for the identification of patients with hereditary nonpolyposiscolorectal cancer. JAMA 2005;293:1986-94.262 - Plaschke JPlaschke J, Engel C, Kruger S, Holinski-Feder E, Pagenstecher C, Mangold E et al. Lower incidence ofcolorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutationscompared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis ColorectalCancer Consortium. J Clin Oncol 2004;22:4486-94.263 - The Polyposis RegistryThe Polyposis Registry. London, UK. Protocol for the management of patients with polyposis. A guide formedical staff, 2006.03/11/08 Erfelijke darmkanker (1.0) 106
Page 1 and 2:
ERFELIJKE DARMKANKERLandelijke rich
Page 3 and 4:
InhoudsopgaveReferenties...........
Page 5 and 6:
Richtlijn: Erfelijke darmkanker (1.
Page 7 and 8:
Page 9 and 10:
Incidentie en risico'sLiteratuurbes
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
DiagnostiekLiteratuurbespreking:Dit
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Restrisico op mutatieRichtlijn: Erf
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53:
BehandelingLiteratuurbespreking:Dit
Page 57 and 58: Richtlijn: Erfelijke darmkanker (1.
Page 71: Richtlijn: Erfelijke darmkanker (1.
Page 116 and 117: Gastroenterology 2004 Jul;127(1):9-
Page 118 and 119: Bijlagen1. Samenstelling werkgroepS
Page 142: Richtlijn: Erfelijke darmkanker (1.
show all

Richtlijn: Erfelijke darmkanker (1.0) - Genootschap van Maag-Darm ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?